Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Sturgill, Elizabeth R ^a   Malouli, Daniel ^a   Hansen, Scott G ^a   Burwitz, Benjamin J ^a   Seo, Seongkyung ^a   Schneider, Christine L ^b   Womack, Jennie L ^a   Verweij, Marieke C ^a   Ventura, Abigail B ^a   Bhusari, Amruta ^a   Jeffries, Krystal M ^a   Legasse, Alfred W ^a   Axthelm, Michael K ^a   Hudson, Amy W ^c   Sacha, Jonah B ^a   Picker, Louis J ^a   Früh, Klaus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CARROLL UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; FAS ANTIGEN; HERMES ANTIGEN; LENTIVIRUS VECTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR; KLRK1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; UL142 PROTEIN, HUMAN HERPESVIRUS 5; US18 PROTEIN, HUMAN CYTOMEGALOVIRUS; US20 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CELL MATURATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MALE; MASS SPECTROMETRY; NATURAL KILLER CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RHESUS MONKEY; T LYMPHOCYTE SUBPOPULATION; VIRUS RECOMBINANT; ANIMAL; IMMUNOLOGY; K-562 CELL LINE; MACACA FASCICULARIS;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNE EVASION; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MEMBRANE GLYCOPROTEINS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; VIRAL PROTEINS;

EID: 84984830187     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005868     Document Type: Article

References (55)

1. Biron CA, Byron KS, Sullivan JL, Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320(26):1731–5. 2543925
2. Brizic I, Lenac Rovis T, Krmpotic A, Jonjic S, MCMV avoidance of recognition and control by NK cells. Seminars in immunopathology. 2014;36(6):641–50. doi: 10.1007/s00281-014-0441-925141793.
3. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S, Controlling NK Cell Responses: Integration of Signals for Activation and Inhibition. Annual review of immunology. 2013;31: PMC3868343.
4. Huard B, Fruh K, A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur J Immunol. 2000;30(2):509–15. Epub 2000/02/12. doi: 10.1002/(SICI)1521-4141(200002)30:02<509::AID-IMMU509>3.0.CO;2-410671206.
5. Raulet DH, Roles of the NKG2D immunoreceptor and its ligands. Nature reviews Immunology. 2003;3(10):781–90. Epub 2003/10/03. doi: 10.1038/nri119914523385.
6. Bahram S, Inoko H, Shiina T, Radosavljevic M, MIC and other NKG2D ligands: from none to too many. Current opinion in immunology. 2005;17(5):505–9. Epub 2005/08/10. doi: 10.1016/j.coi.2005.07.01616087327.
7. Slavuljica I, Krmpotic A, Jonjic S, Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Frontiers in immunology. 2011;2:85. Epub 2011/01/01. doi: 10.3389/fimmu.2011.0008522566874; PubMed Central PMCID: PMCPMC3342069.
8. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14(2):123–33. Epub 2001/03/10. S1074-7613(01)00095-4 [pii]. 11239445.
9. Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T, Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol. 2003;170(8):4196–200. 12682252.
10. Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, Eknigk U, et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol. 2003;33(1):194–203. 12594848
11. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. The Journal of experimental medicine. 2003;197(11):1427–39. Epub 2003/06/05. doi: 10.1084/jem.20022059 jem.20022059 [pii]. 12782710; PubMed Central PMCID: PMC2193902.
12. Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J, ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol. 2009;39(11):3207–16. doi: 10.1002/eji.20093950219658097
13. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, et al. Host immune system gene targeting by a viral miRNA. Science. 2007;317(5836):376–81. 17641203.
14. Bennett NJ, Ashiru O, Morgan FJ, Pang Y, Okecha G, Eagle RA, et al. Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus. J Immunol. 2010;185(2):1093–102. doi: 10.4049/jimmunol.100078920530255.
15. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D, Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochemical and biophysical research communications. 2006;346(1):175–81. doi: 10.1016/j.bbrc.2006.05.09216750166.
16. Fielding CA, Aicheler R, Stanton RJ, Wang EC, Han S, Seirafian S, et al. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS pathogens. 2014;10(5):e1004058. Epub 2014/05/03. doi: 10.1371/journal.ppat.1004058 PPATHOGENS-D-13-01495 [pii]. 24787765; PubMed Central PMCID: PMC4006889.
17. Sun JC, Lanier LL, The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors. Viruses. 2009;1(3):362. Epub 2010/02/13. doi: 10.3390/v103036220151027; PubMed Central PMCID: PMC2819288.
18. Seidel E, Le VT, Bar-On Y, Tsukerman P, Enk J, Yamin R, et al. Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA *008 to Escape Elimination by NK Cells. Cell reports. 2015. Epub 2015/02/17. doi: 10.1016/j.celrep.2015.01.02925683719.
19. Slavuljica I, Busche A, Babic M, Mitrovic M, Gasparovic I, Cekinovic D, et al. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest. 2010;120(12):4532–45. Epub 2010/11/26. doi: 10.1172/JCI43961 43961 [pii]. 21099111; PubMed Central PMCID: PMC2993599.
20. Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, et al. Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1gamma. Proc Natl Acad Sci U S A. 2013;110(41):16550–5. Epub 2013/09/21. doi: 10.1073/pnas.1310215110 1310215110 [pii]. 24052528; PubMed Central PMCID: PMC3799388.
21. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature. 2011;473(7348):523–7. doi: 10.1038/nature1000321562493; PubMed Central PMCID: PMC3102768.
22. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nature medicine. 2009;15(3):293–9. Epub 2009/02/17. doi: 10.1038/nm.193519219024; PubMed Central PMCID: PMCPMC2720091.
23. Hansen SG, Piatak M, Jr.Ventura AB, Hughes CM, Gilbride RM, Ford JC, et al. Immune clearance of highly pathogenic SIV infection. Nature. 2013;502(7469):100–4. doi: 10.1038/nature1251924025770; PubMed Central PMCID: PMC3849456.
24. Hansen SG, Wu HL, Burwitz BJ, Hughes CM, Hammond KB, Ventura AB, et al. Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E. Science. 2016;351(6274):714–20. Epub 2016/01/23. doi: 10.1126/science.aac947526797147; PubMed Central PMCID: PMCPMC4769032.
25. Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, Scholz I, et al. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science. 2013;340(6135):1237874. doi: 10.1126/science.123787423704576; PubMed Central PMCID: PMC3816976.
26. Malouli D, Nakayasu ES, Viswanathan K, Camp DG, 2ndChang WL, Barry PA, et al. Reevaluation of the Coding Potential and Proteomic Analysis of the BAC-Derived Rhesus Cytomegalovirus Strain 68–1. Journal of virology. 2012;86(17):8959–73. Epub 2012/06/22. doi: 10.1128/JVI.01132-1222718821.
27. Pande NT, Powers C, Ahn K, Fruh K, Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. Journal of virology. 2005;79(9):5786–98. Epub 2005/04/14. doi: 10.1128/JVI.79.9.5786-5798.200515827193; PubMed Central PMCID: PMC1082751.
28. Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, Siess D, et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science. 2010;328(5974):102–6. doi: 10.1126/science.118535020360110; PubMed Central PMCID: PMC2883175.
29. Meyer A, Carapito R, Ott L, Radosavljevic M, Georgel P, Adams EJ, et al. High diversity of MIC genes in non-human primates. Immunogenetics. 2014;66(9–10):581–7. doi: 10.1007/s00251-014-0791-425073428.
30. Kasahara M, Yoshida S, Immunogenetics of the NKG2D ligand gene family. Immunogenetics. 2012;64(12):855–67. doi: 10.1007/s00251-012-0638-922843249.
31. Schneider CL, Hudson AW, The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB. PLoS pathogens. 2011;7(11):e1002362. doi: 10.1371/journal.ppat.100236222102813; PubMed Central PMCID: PMC3213103.
32. Aguera-Gonzalez S, Boutet P, Reyburn HT, Vales-Gomez M, Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding. J Immunol. 2009;182(8):4800–8. Epub 2009/04/04. doi: 10.4049/jimmunol.080071319342658.
33. Whitmer T, Malouli D, Uebelhoer LS, DeFilippis VR, Früh K, Verweij MC, The ORF61 protein encoded by Simian Varicella Virus and Varicella Zoster Virus inhibits NFκB signaling by interfering with IκBα degradation. Journal of Virology. 2015. doi: 10.1128/jvi.01149-15
34. Hansen SG, Strelow LI, Franchi DC, Anders DG, Wong SW, Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol. 2003;77(12):6620–36. Epub 2003/05/28. 12767982; PubMed Central PMCID: PMCPMC156187.
35. Stanton RJ, Prod'homme V, Purbhoo MA, Moore M, Aicheler RJ, Heinzmann M, et al. HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. Cell host & microbe. 2014;16(2):201–14. Epub 2014/08/15. doi: 10.1016/j.chom.2014.07.00525121749; PubMed Central PMCID: PMCPMC4150922.
36. Mavilio D, Benjamin J, Kim D, Lombardo G, Daucher M, Kinter A, et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood. 2005;106(5):1718–25. 15899917
37. Carter DL, Shieh TM, Blosser RL, Chadwick KR, Margolick JB, Hildreth JEK, et al. CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry. 1999;37(1):41–50. doi: 10.1002/(SICI)1097-0320(19990901)37:1<41::AID-CYTO5>3.0.CO;2-410451505
38. Madden LJ, Zandonatti MA, Flynn CT, Taffe MA, Marcondes MC, Schmitz JE, et al. CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol. 2004;10Suppl 1:58–66. Epub 2004/02/26. EEW94RBBX0NQJBY9 [pii]. 14982741.
39. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. The Journal of experimental medicine. 2005;202(5):673–85. Epub 2005/09/09. doi: 10.1084/jem.2005088216147978; PubMed Central PMCID: PMCPMC2212883.
40. Shikano S, Li M, Membrane receptor trafficking: evidence of proximal and distal zones conferred by two independent endoplasmic reticulum localization signals. Proc Natl Acad Sci U S A. 2003;100(10):5783–8. Epub 2003/05/02. doi: 10.1073/pnas.1031748100 1031748100 [pii]. 12724521; PubMed Central PMCID: PMC156278.
41. Mohr CA, Arapovic J, Muhlbach H, Panzer M, Weyn A, Dolken L, et al. A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol. 2010;84(15):7730–42. Epub 2010/05/14. doi: 10.1128/jvi.02696-0920463067; PubMed Central PMCID: PMCPmc2897632.
42. Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB, Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS pathogens. 2011;7(10):e1002295. Epub 2011/10/15. doi: 10.1371/journal.ppat.100229521998590; PubMed Central PMCID: PMCPmc3188546.
43. Lilja AE, Chang WL, Barry PA, Becerra SP, Shenk TE, Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor. J Virol. 2008;82(5):2170–81. Epub 2007/12/21. JVI.02316-07 [pii] doi: 10.1128/JVI.02316-0718094178; PubMed Central PMCID: PMC2258942.
44. Lilja AE, Shenk T, Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types. Proc Natl Acad Sci U S A. 2008;105(50):19950–5. 19064925. doi: 10.1073/pnas.0811063106
45. Li G, Nguyen CC, Ryckman BJ, Britt WJ, Kamil JP, A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism. Proceedings of the National Academy of Sciences. 2015;112(14):4471–6. doi: 10.1073/pnas.1419875112
46. Steinle A, Groh V, Spies T, Diversification, expression, and γδ T cell recognition of evolutionarily distant members of the MIC family of major histocompatibility complex class I-related molecules. Proceedings of the National Academy of Sciences. 1998;95(21):12510–5. doi: 10.1073/pnas.95.21.12510
47. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001;73(1):56–65. Epub 2001/05/16. doi: 10.1006/geno.2000.645111352566.
48. Chang WLW, Barry PA, Cloning of the Full-Length Rhesus Cytomegalovirus Genome as an Infectious and Self-Excisable Bacterial Artificial Chromosome for Analysis of Viral Pathogenesis. J Virol. 2003;77(9):5073–83. doi: 10.1128/jvi.77.9.5073-5083.200312692210
49. Tischer BK, Smith GA, Osterrieder N, Braman J, En Passant Mutagenesis: A Two Step Markerless Red Recombination System. In: Vitro Mutagenesis Protocols: Third Edition. Totowa, NJ: Humana Press; 2010. p. 421–30.
50. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proceedings of the National Academy of Sciences. 2003;100(25):14976–81. doi: 10.1073/pnas.2136652100
51. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML, Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997;71(3):1842–9. 9032314
52. Stanton RJ, McSharry BP, Armstrong M, Tomasec P, Wilkinson GWG, Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function. BioTechniques. 2008;45(6):659–68. doi: 10.2144/00011299319238796
53. Yan F-F, Pratt EB, Chen P-C, Wang F, Skach WR, David LL, et al. Role of Hsp90 in Biogenesis of the β-Cell ATP-sensitive Potassium Channel Complex. Molecular Biology of the Cell. 2010;21(12):1945–54. doi: 10.1091/mbc.E10-02-011620427569
54. Wilmarth P, Riviere M, David L, Techniques for accurate protein identification in shotgun proteomic studies of human, mouse, bovine, and chicken lenses. j ocul biol dis inform. 2009;2(4):223–34. doi: 10.1007/s12177-009-9042-6
55. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics (Oxford, England). 2009;25(9):1189–91. Epub 2009/01/20. doi: 10.1093/bioinformatics/btp03319151095; PubMed Central PMCID: PMCPMC2672624.